RADNOR, Pa.--(BUSINESS WIRE)--QR Pharma, Inc., a developer of novel compounds to treat Alzheimer’s disease (AD), announced today that Jeffrey Cummings, MD, Rachelle Doody, MD, PhD, Martin Farlow, MD and Mary Sano, PhD, have been elected to QR’s Medical Advisory Board.
